These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4978679)

  • 21. Studies on human malaria in Aotus monkeys. IV. Development of Plasmodium falciparum in two subspecies of Aotus trivirgatus.
    Collins WE; Stanfill PS; Skinner JC; Harrison AJ; Smith CS
    J Parasitol; 1974 Apr; 60(2):355-8. PubMed ID: 4132255
    [No Abstract]   [Full Text] [Related]  

  • 22. Susceptibility of owl monkeys to Plasmodium falciparum infection in relation to location of origin, phenotype, and karyotype.
    Taylor DW; Siddiqui WA
    J Parasitol; 1979 Apr; 65(2):267-71. PubMed ID: 109608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malaria: the most important emergency in subjects returning from the tropics].
    Schubarth P
    Schweiz Med Wochenschr; 1993 May; 123(17):906-10. PubMed ID: 8497778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The drug response of a normal and a multi-resistant strain of P. falciparum to sulphalene.
    Martin DC; Arnold JD
    Trans R Soc Trop Med Hyg; 1968; 62(6):810-5. PubMed ID: 4891862
    [No Abstract]   [Full Text] [Related]  

  • 25. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children.
    Nirmala ; Kumar A; Kapoor AK; Lal B; Dutta GP; Swaroop A
    Exp Parasitol; 1999 Sep; 93(1):33-7. PubMed ID: 10464036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections.
    Schmidt LH
    Am J Trop Med Hyg; 1978 Jul; 27(4):671-702. PubMed ID: 99055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinine, pyrimethamine, and sulphorthodimethoxine: clinical response, plasma levels, and urinary excretion during the initial attack of naturally acquired falciparum malaria.
    Brooks MH; Malloy JP; Bartelloni PJ; Sheehy TW; Barry KG
    Clin Pharmacol Ther; 1969; 10(1):85-91. PubMed ID: 4884297
    [No Abstract]   [Full Text] [Related]  

  • 29. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon ; Tan Puay Eng
    Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
    [No Abstract]   [Full Text] [Related]  

  • 31. Sulphadoxine and pyrimethamine as treatment for acute Plasmodium falciparum malaria.
    Simpson B; Jamieson WS; Dimond AH
    Trans R Soc Trop Med Hyg; 1972; 66(2):222-4. PubMed ID: 4558823
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunity to Plasmodium falciparum in owl monkeys (Aotus trivirgatus).
    Voller A; Richards WH
    Z Tropenmed Parasitol; 1970 Jun; 21(2):159-66. PubMed ID: 4987847
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathology of Plasmodium falciparum in owl monkeys.
    Ridley DS; Voller A; Richards WH
    Trans R Soc Trop Med Hyg; 1969; 63(1):2. PubMed ID: 4978043
    [No Abstract]   [Full Text] [Related]  

  • 34. Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey--model systems for basic biological and chemotherapeutic studies.
    Schmidt LH
    Trans R Soc Trop Med Hyg; 1973; 67(4):446-74. PubMed ID: 4206524
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the antimalarial property of 4-methoxy-6-sulfanilamido-pyrimidine monohydrate (sulfamonomethoxine: DJ-1550) and on its effect on the chloroquine-resistant malaria.
    Yoshinaga T; Tsutsumi Y; Tsunoda K; Yamamura Y
    Arzneimittelforschung; 1970 Sep; 20(9):1206-10. PubMed ID: 4922319
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of chloroquine resistant falciparum malaria.
    Blount RE
    Trans Am Clin Climatol Assoc; 1967; 78():196-204. PubMed ID: 5339079
    [No Abstract]   [Full Text] [Related]  

  • 37. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
    Best Plummer W; Pinto Pereira L
    Int J Infect Dis; 2008 Nov; 12(6):e27-31. PubMed ID: 18573671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of malaria in children.
    Stauffer W; Fischer PR
    Clin Infect Dis; 2003 Nov; 37(10):1340-8. PubMed ID: 14583868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 40. Modified antimalarial treatment for chloroquin resistant plasmodium falciparum infection.
    Singh PS
    J Assoc Physicians India; 1995 Jan; 43(1):72-3. PubMed ID: 9282660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.